← All indications
Ketosis
A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).
Subtype terms (1)
More specific conditions that are subtypes of Ketosis in the MeSH hierarchy.
- Diabetic Ketoacidosis
15 drugs (12 approved, 3 experimental)
Drugs by status
Phase 4 trials (4)
Phase 3 trials (3)
Phase 2 trials (3)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (18)
- Novo Nordisk
- Aarhus University
- Augusta University
- Baylor University
- Chattanooga-Hamilton County Hospital Authority
- University of Maryland
- State University of New York
- Vanderbilt University
- Karolinska Institute
- Rush University
- Hennepin Healthcare
- University of Texas at Houston
- State University of New York, Buffalo
- Linkoping University
- University of Western Ontario
- Vrinnevi Hospital
- Bournemouth University
- Dorset HealthCare University NHS Foundation Trust